Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TapImmune Inc (NASDAQ:TPIV)

3.16
Delayed Data
As of 3:59pm ET
 -0.12 / -3.66%
Today’s Change
2.68
Today|||52-Week Range
6.20
-18.56%
Year-to-Date
No recent news for TapImmune Inc.

Today’s Trading

Previous close3.28
Today’s open3.21
Day’s range3.15 - 3.21
Volume6,305
Average volume (3 months)35,848
Market cap$33.3M
Dividend yield--
Data as of 3:59pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)+92.31%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.47

Competitors

 Today’s
change
Today’s
% change
CATBCatabasis Pharmaceut...-0.07-2.97%
CBLICleveland Biolabs In...+0.02+0.63%
VKTXViking Therapeutics ...-0.02-0.96%
SLNOSoleno Therapeutics ...-0.08-3.30%
Data as of 3:59pm ET, 10/17/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$2.5M
Net profit margin--

Profile

Sector
Consumer Services
Industry
Other Consumer Services
President, Chief Executive Officer &
Director
Peter L. Hoang
Chief Financial Officer, Secretary &
Treasurer
Michael J. Loiacono
Corporate headquarters
Jacksonville, Florida

Forecasts